These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18407135)

  • 21. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
    Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
    J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Low-renin hypertension and inherited mineralocorticoid diseases].
    Kastelan D; Giljević Z; Perković Z; Plavsić V; Breskovac L; Aganović I; Korsić M
    Lijec Vjesn; 1999; 121(7-8):245-9. PubMed ID: 10573960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid-remediable aldosteronism.
    McMahon GT; Dluhy RG
    Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):682-6. PubMed ID: 15761539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disorders of the aldosterone synthase and steroid 11beta-hydroxylase deficiencies.
    Peter M; Dubuis JM; Sippell WG
    Horm Res; 1999; 51(5):211-22. PubMed ID: 10559665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism.
    MacConnachie AA; Kelly KF; McNamara A; Loughlin S; Gates LJ; Inglis GC; Jamieson A; Connell JM; Haites NE
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4328-31. PubMed ID: 9851772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.
    Kamrath C; Maser-Gluth C; Haag C; Schulze E
    Horm Res Paediatr; 2011; 76(2):93-8. PubMed ID: 21625068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene.
    Mulatero P; Veglio F; Pilon C; Rabbia F; Zocchi C; Limone P; Boscaro M; Sonino N; Fallo F
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2573-5. PubMed ID: 9661646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Update on Familial Hyperaldosteronism.
    Korah HE; Scholl UI
    Horm Metab Res; 2015 Dec; 47(13):941-6. PubMed ID: 26445452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary aldosteronism.
    Gordon RD
    J Endocrinol Invest; 1995; 18(7):495-511. PubMed ID: 9221268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion hybrid genes, due to unequal crossing over between CYP11B1 (11beta-hydroxylase) and CYP11B2(aldosterone synthase) cause steroid 11beta-hydroxylase deficiency and congenital adrenal hyperplasia.
    Portrat S; Mulatero P; Curnow KM; Chaussain JL; Morel Y; Pascoe L
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3197-201. PubMed ID: 11443188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoid-remediable aldosteronism and pregnancy.
    Wyckoff JA; Seely EW; Hurwitz S; Anderson BF; Lifton RP; Dluhy RG
    Hypertension; 2000 Feb; 35(2):668-72. PubMed ID: 10679515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal salt-wasting and 11 beta-hydroxylase deficiency in a child carrying a homozygous deletion hybrid CYP11B2 (aldosterone synthase)-CYP11B1 (11 beta-hydroxylase).
    Ezquieta B; Luzuriaga C
    Clin Genet; 2004 Sep; 66(3):229-35. PubMed ID: 15324322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Treasure your exceptions': what we can learn from autosomal-dominant inherited forms of hypertension.
    Luft FC; Schuster H; Bilginturan N; Wienker T
    J Hypertens; 1995 Dec; 13(12 Pt 2):1535-8. PubMed ID: 8903606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unequal crossing-over between aldosterone synthase and 11beta-hydroxylase genes causes congenital adrenal hyperplasia.
    Hampf M; Dao NT; Hoan NT; Bernhardt R
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4445-52. PubMed ID: 11549691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
    Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
    J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A German family with glucocorticoid-remediable aldosteronism.
    Vonend O; Altenhenne C; Büchner NJ; Dekomien G; Maser-Gluth C; Weiner SM; Sellin L; Hofebauer S; Epplen JT; Rump LC
    Nephrol Dial Transplant; 2007 Apr; 22(4):1123-30. PubMed ID: 17277347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disorders of steroid 11 beta-hydroxylase isozymes.
    White PC; Curnow KM; Pascoe L
    Endocr Rev; 1994 Aug; 15(4):421-38. PubMed ID: 7988480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldosterone secretion: a molecular perspective.
    Boon WC; Coghlan JP; Curnow KM; McDougall JG
    Trends Endocrinol Metab; 1997 Nov; 8(9):346-54. PubMed ID: 18406824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 5: Genetic diagnosis of primary aldosteronism.
    Zennaro MC; Jeunemaitre X
    Ann Endocrinol (Paris); 2016 Jul; 77(3):214-9. PubMed ID: 27315758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary aldosteronism: learning from the study of familial varieties.
    Stowasser M; Gordon RD
    J Hypertens; 2000 Sep; 18(9):1165-76. PubMed ID: 10994747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.